Current accounts of antimicrobial resistance: stabilisation, individualisation and antibiotics as infrastructure
- PMID: 31157116
- PMCID: PMC6542671
- DOI: 10.1057/s41599-019-0263-4
Current accounts of antimicrobial resistance: stabilisation, individualisation and antibiotics as infrastructure
Abstract
Antimicrobial resistance (AMR) is one of the latest issues to galvanise political and financial investment as an emerging global health threat. This paper explores the construction of AMR as a problem, following three lines of analysis. First, an examination of some of the ways in which AMR has become an object for action-through defining, counting and projecting it. Following Lakoff's work on emerging infectious diseases, the paper illustrates that while an 'actuarial' approach to AMR may be challenging to stabilise due to definitional and logistical issues, it has been successfully stabilised through a 'sentinel' approach that emphasises the threat of AMR. Second, the paper draws out a contrast between the way AMR is formulated in terms of a problem of connectedness-a 'One Health' issue-and the frequent solutions to AMR being focused on individual behaviour. The paper suggests that AMR presents an opportunity to take seriously connections, scale and systems but that this effort is undermined by the prevailing tendency to reduce health issues to matters for individual responsibility. Third, the paper takes AMR as a moment of infrastructural inversion (Bowker and Star) when antimicrobials and the work they do are rendered more visible. This leads to the proposal of antibiotics as infrastructure-part of the woodwork that we take for granted, and entangled with our ways of doing life, in particular modern life. These explorations render visible the ways social, economic and political frames continue to define AMR and how it may be acted upon, which opens up possibilities for reconfiguring AMR research and action.
Conflict of interest statement
Competing interests: The author declares no competing interests.
Figures


References
-
- Abat C, Rolain J, Dubourg G, Fournier P, Chaudet H, Raoult D. Evaluating the clinical burden and mortality attributable to antibiotic resistance: the disparity of empirical data and simple model estimations. Clin Infect Dis. 2017;65(suppl_1):S58–S63. - PubMed
-
- Adams V, editor. Metrics: what counts in global health. Durham: Duke University Press; 2016.
-
- AMR Industry Alliance (2016) Declaration by the pharmaceutical, biotechnology and diagnostics industries on combating antimicrobial resistance. International Federation of Pharmaceutical Manufacturers & Associations. https://www.amrindustryalliance.org/wp-content/uploads/2017/12/AMR-Indus.... Accessed Oct 2018
-
- Anderson B. Preemption, precaution, preparedness: anticipatory action and future geographies. Prog Hum Geogr. 2010;34:777–798.
-
- Arnold SR and Straus SE (2005) Interventions to improve antibiotic prescribing practices in ambulatory care. Cochrane Database Syst Rev (4): CD003539. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003539.pub2/... - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Other Literature Sources